nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—lung cancer	0.2	0.561	CbGaD
Rabeprazole—CYP1A1—lung cancer	0.156	0.439	CbGaD
Rabeprazole—ABCG2—Topotecan—lung cancer	0.0356	0.0831	CbGbCtD
Rabeprazole—ABCG2—Gefitinib—lung cancer	0.0326	0.076	CbGbCtD
Rabeprazole—ABCG2—Teniposide—lung cancer	0.0316	0.0737	CbGbCtD
Rabeprazole—CYP1A1—Gefitinib—lung cancer	0.0301	0.0702	CbGbCtD
Rabeprazole—ABCG2—Erlotinib—lung cancer	0.0193	0.045	CbGbCtD
Rabeprazole—CYP1A1—Erlotinib—lung cancer	0.0178	0.0415	CbGbCtD
Rabeprazole—ABCG2—Paclitaxel—lung cancer	0.0176	0.0412	CbGbCtD
Rabeprazole—ABCG2—Irinotecan—lung cancer	0.0174	0.0406	CbGbCtD
Rabeprazole—CYP2C19—Gefitinib—lung cancer	0.0146	0.034	CbGbCtD
Rabeprazole—ABCG2—Cisplatin—lung cancer	0.0142	0.0331	CbGbCtD
Rabeprazole—CYP2C19—Teniposide—lung cancer	0.0141	0.033	CbGbCtD
Rabeprazole—ABCG2—Etoposide—lung cancer	0.0139	0.0325	CbGbCtD
Rabeprazole—ABCG2—Docetaxel—lung cancer	0.0128	0.0298	CbGbCtD
Rabeprazole—CYP2C9—Gefitinib—lung cancer	0.0121	0.0283	CbGbCtD
Rabeprazole—CYP2C9—Teniposide—lung cancer	0.0117	0.0274	CbGbCtD
Rabeprazole—CYP2D6—Gefitinib—lung cancer	0.0111	0.0258	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—lung cancer	0.00951	0.0222	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—lung cancer	0.00921	0.0215	CbGbCtD
Rabeprazole—CYP2D6—Vinorelbine—lung cancer	0.00853	0.0199	CbGbCtD
Rabeprazole—CYP1A2—Erlotinib—lung cancer	0.00795	0.0185	CbGbCtD
Rabeprazole—CYP3A4—Topotecan—lung cancer	0.0077	0.018	CbGbCtD
Rabeprazole—CYP3A4—Gefitinib—lung cancer	0.00704	0.0164	CbGbCtD
Rabeprazole—CYP3A4—Teniposide—lung cancer	0.00683	0.0159	CbGbCtD
Rabeprazole—CYP2C9—Paclitaxel—lung cancer	0.00655	0.0153	CbGbCtD
Rabeprazole—CYP2D6—Erlotinib—lung cancer	0.00655	0.0153	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—lung cancer	0.00575	0.0134	CbGbCtD
Rabeprazole—CYP3A4—Vinorelbine—lung cancer	0.00542	0.0127	CbGbCtD
Rabeprazole—CYP2C9—Cisplatin—lung cancer	0.00527	0.0123	CbGbCtD
Rabeprazole—CYP2D6—Vinblastine—lung cancer	0.00526	0.0123	CbGbCtD
Rabeprazole—CYP3A4—Crizotinib—lung cancer	0.00432	0.0101	CbGbCtD
Rabeprazole—CYP3A4—Erlotinib—lung cancer	0.00416	0.00971	CbGbCtD
Rabeprazole—CYP3A4—Paclitaxel—lung cancer	0.00381	0.00889	CbGbCtD
Rabeprazole—CYP3A4—Irinotecan—lung cancer	0.00376	0.00877	CbGbCtD
Rabeprazole—CYP3A4—Vinblastine—lung cancer	0.00334	0.0078	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—lung cancer	0.00323	0.00754	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—lung cancer	0.00301	0.00703	CbGbCtD
Rabeprazole—CYP3A4—Docetaxel—lung cancer	0.00276	0.00643	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—lung cancer	0.00205	0.00479	CbGbCtD
Rabeprazole—Omeprazole—ABCC3—lung cancer	0.000885	0.257	CrCbGaD
Rabeprazole—Pantoprazole—ABCG2—lung cancer	0.000528	0.153	CrCbGaD
Rabeprazole—Omeprazole—ABCG2—lung cancer	0.00043	0.125	CrCbGaD
Rabeprazole—Lansoprazole—ABCG2—lung cancer	0.000393	0.114	CrCbGaD
Rabeprazole—Omeprazole—CYP1A1—lung cancer	0.000337	0.0978	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—lung cancer	0.000308	0.0895	CrCbGaD
Rabeprazole—Pantoprazole—ABCB1—lung cancer	0.00022	0.0638	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—lung cancer	0.000179	0.052	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—lung cancer	0.000164	0.0475	CrCbGaD
Rabeprazole—Dyspnoea—Paclitaxel—lung cancer	4.03e-05	0.000264	CcSEcCtD
Rabeprazole—Somnolence—Paclitaxel—lung cancer	4.02e-05	0.000263	CcSEcCtD
Rabeprazole—Decreased appetite—Etoposide—lung cancer	4e-05	0.000262	CcSEcCtD
Rabeprazole—Arthralgia—Docetaxel—lung cancer	3.99e-05	0.000262	CcSEcCtD
Rabeprazole—Myalgia—Docetaxel—lung cancer	3.99e-05	0.000262	CcSEcCtD
Rabeprazole—Chest pain—Docetaxel—lung cancer	3.99e-05	0.000262	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—lung cancer	3.99e-05	0.000261	CcSEcCtD
Rabeprazole—Nausea—Vinorelbine—lung cancer	3.99e-05	0.000261	CcSEcCtD
Rabeprazole—Dyspepsia—Paclitaxel—lung cancer	3.98e-05	0.00026	CcSEcCtD
Rabeprazole—Body temperature increased—Cisplatin—lung cancer	3.98e-05	0.00026	CcSEcCtD
Rabeprazole—Asthenia—Irinotecan—lung cancer	3.97e-05	0.00026	CcSEcCtD
Rabeprazole—Constipation—Etoposide—lung cancer	3.94e-05	0.000258	CcSEcCtD
Rabeprazole—Pain—Etoposide—lung cancer	3.94e-05	0.000258	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—lung cancer	3.93e-05	0.000257	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—lung cancer	3.93e-05	0.000257	CcSEcCtD
Rabeprazole—Decreased appetite—Paclitaxel—lung cancer	3.93e-05	0.000257	CcSEcCtD
Rabeprazole—Dry mouth—Docetaxel—lung cancer	3.91e-05	0.000256	CcSEcCtD
Rabeprazole—Hepatitis—Methotrexate—lung cancer	3.88e-05	0.000254	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—lung cancer	3.88e-05	0.000254	CcSEcCtD
Rabeprazole—Asthenia—Gemcitabine—lung cancer	3.87e-05	0.000254	CcSEcCtD
Rabeprazole—Constipation—Paclitaxel—lung cancer	3.86e-05	0.000253	CcSEcCtD
Rabeprazole—Pain—Paclitaxel—lung cancer	3.86e-05	0.000253	CcSEcCtD
Rabeprazole—Confusional state—Docetaxel—lung cancer	3.86e-05	0.000253	CcSEcCtD
Rabeprazole—Pharyngitis—Methotrexate—lung cancer	3.86e-05	0.000253	CcSEcCtD
Rabeprazole—Urinary tract disorder—Methotrexate—lung cancer	3.84e-05	0.000251	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—lung cancer	3.84e-05	0.000251	CcSEcCtD
Rabeprazole—Oedema—Docetaxel—lung cancer	3.83e-05	0.000251	CcSEcCtD
Rabeprazole—Anaphylactic shock—Docetaxel—lung cancer	3.83e-05	0.000251	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—lung cancer	3.82e-05	0.00025	CcSEcCtD
Rabeprazole—Pruritus—Gemcitabine—lung cancer	3.82e-05	0.00025	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—lung cancer	3.81e-05	0.000249	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—lung cancer	3.8e-05	0.000249	CcSEcCtD
Rabeprazole—Feeling abnormal—Etoposide—lung cancer	3.8e-05	0.000249	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—lung cancer	3.79e-05	0.000248	CcSEcCtD
Rabeprazole—Diarrhoea—Irinotecan—lung cancer	3.79e-05	0.000248	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—lung cancer	3.77e-05	0.000247	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Etoposide—lung cancer	3.77e-05	0.000247	CcSEcCtD
Rabeprazole—Shock—Docetaxel—lung cancer	3.77e-05	0.000247	CcSEcCtD
Rabeprazole—Thrombocytopenia—Docetaxel—lung cancer	3.75e-05	0.000246	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—lung cancer	3.74e-05	0.000245	CcSEcCtD
Rabeprazole—Tachycardia—Docetaxel—lung cancer	3.74e-05	0.000245	CcSEcCtD
Rabeprazole—Feeling abnormal—Paclitaxel—lung cancer	3.72e-05	0.000244	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.71e-05	0.000243	CcSEcCtD
Rabeprazole—Hypersensitivity—Cisplatin—lung cancer	3.71e-05	0.000243	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Paclitaxel—lung cancer	3.69e-05	0.000242	CcSEcCtD
Rabeprazole—Diarrhoea—Gemcitabine—lung cancer	3.69e-05	0.000242	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—lung cancer	3.67e-05	0.000241	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—lung cancer	3.67e-05	0.000241	CcSEcCtD
Rabeprazole—Dizziness—Irinotecan—lung cancer	3.66e-05	0.00024	CcSEcCtD
Rabeprazole—Urticaria—Etoposide—lung cancer	3.66e-05	0.00024	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—lung cancer	3.65e-05	0.000239	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—lung cancer	3.65e-05	0.000239	CcSEcCtD
Rabeprazole—Anorexia—Docetaxel—lung cancer	3.65e-05	0.000239	CcSEcCtD
Rabeprazole—Body temperature increased—Etoposide—lung cancer	3.64e-05	0.000239	CcSEcCtD
Rabeprazole—Abdominal pain—Etoposide—lung cancer	3.64e-05	0.000239	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—lung cancer	3.64e-05	0.000239	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—lung cancer	3.64e-05	0.000239	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—lung cancer	3.63e-05	0.000238	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—lung cancer	3.62e-05	0.000237	CcSEcCtD
Rabeprazole—Asthenia—Cisplatin—lung cancer	3.61e-05	0.000236	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—lung cancer	3.59e-05	0.000235	CcSEcCtD
Rabeprazole—Urticaria—Paclitaxel—lung cancer	3.59e-05	0.000235	CcSEcCtD
Rabeprazole—Hypotension—Docetaxel—lung cancer	3.58e-05	0.000234	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—lung cancer	3.57e-05	0.000234	CcSEcCtD
Rabeprazole—Body temperature increased—Paclitaxel—lung cancer	3.57e-05	0.000234	CcSEcCtD
Rabeprazole—Abdominal pain—Paclitaxel—lung cancer	3.57e-05	0.000234	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—lung cancer	3.53e-05	0.000231	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—lung cancer	3.52e-05	0.000231	CcSEcCtD
Rabeprazole—Vomiting—Irinotecan—lung cancer	3.52e-05	0.000231	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—lung cancer	3.52e-05	0.00023	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—lung cancer	3.5e-05	0.000229	CcSEcCtD
Rabeprazole—Rash—Irinotecan—lung cancer	3.49e-05	0.000229	CcSEcCtD
Rabeprazole—Dermatitis—Irinotecan—lung cancer	3.49e-05	0.000229	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Docetaxel—lung cancer	3.49e-05	0.000228	CcSEcCtD
Rabeprazole—Chills—Methotrexate—lung cancer	3.49e-05	0.000228	CcSEcCtD
Rabeprazole—Headache—Irinotecan—lung cancer	3.47e-05	0.000227	CcSEcCtD
Rabeprazole—Insomnia—Docetaxel—lung cancer	3.46e-05	0.000227	CcSEcCtD
Rabeprazole—Diarrhoea—Cisplatin—lung cancer	3.44e-05	0.000225	CcSEcCtD
Rabeprazole—Paraesthesia—Docetaxel—lung cancer	3.44e-05	0.000225	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—lung cancer	3.43e-05	0.000225	CcSEcCtD
Rabeprazole—Vomiting—Gemcitabine—lung cancer	3.43e-05	0.000225	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—lung cancer	3.42e-05	0.000224	CcSEcCtD
Rabeprazole—Dyspnoea—Docetaxel—lung cancer	3.41e-05	0.000224	CcSEcCtD
Rabeprazole—Somnolence—Docetaxel—lung cancer	3.4e-05	0.000223	CcSEcCtD
Rabeprazole—Rash—Gemcitabine—lung cancer	3.4e-05	0.000223	CcSEcCtD
Rabeprazole—Dermatitis—Gemcitabine—lung cancer	3.4e-05	0.000223	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—lung cancer	3.39e-05	0.000222	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—lung cancer	3.38e-05	0.000221	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—lung cancer	3.38e-05	0.000221	CcSEcCtD
Rabeprazole—Headache—Gemcitabine—lung cancer	3.38e-05	0.000221	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—lung cancer	3.37e-05	0.000221	CcSEcCtD
Rabeprazole—Dyspepsia—Docetaxel—lung cancer	3.37e-05	0.000221	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—lung cancer	3.36e-05	0.00022	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—lung cancer	3.34e-05	0.000219	CcSEcCtD
Rabeprazole—Decreased appetite—Docetaxel—lung cancer	3.33e-05	0.000218	CcSEcCtD
Rabeprazole—Hypersensitivity—Paclitaxel—lung cancer	3.33e-05	0.000218	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—lung cancer	3.32e-05	0.000218	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—lung cancer	3.31e-05	0.000217	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—lung cancer	3.31e-05	0.000217	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—lung cancer	3.31e-05	0.000217	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—lung cancer	3.3e-05	0.000216	CcSEcCtD
Rabeprazole—Nausea—Irinotecan—lung cancer	3.29e-05	0.000215	CcSEcCtD
Rabeprazole—Constipation—Docetaxel—lung cancer	3.27e-05	0.000214	CcSEcCtD
Rabeprazole—Pain—Docetaxel—lung cancer	3.27e-05	0.000214	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—lung cancer	3.27e-05	0.000214	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—lung cancer	3.26e-05	0.000213	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—lung cancer	3.24e-05	0.000212	CcSEcCtD
Rabeprazole—Asthenia—Paclitaxel—lung cancer	3.24e-05	0.000212	CcSEcCtD
Rabeprazole—Nausea—Gemcitabine—lung cancer	3.2e-05	0.00021	CcSEcCtD
Rabeprazole—Vomiting—Cisplatin—lung cancer	3.2e-05	0.000209	CcSEcCtD
Rabeprazole—Pruritus—Paclitaxel—lung cancer	3.2e-05	0.000209	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—lung cancer	3.19e-05	0.000209	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—lung cancer	3.18e-05	0.000208	CcSEcCtD
Rabeprazole—Rash—Cisplatin—lung cancer	3.17e-05	0.000208	CcSEcCtD
Rabeprazole—Dermatitis—Cisplatin—lung cancer	3.17e-05	0.000207	CcSEcCtD
Rabeprazole—Feeling abnormal—Docetaxel—lung cancer	3.16e-05	0.000207	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—lung cancer	3.15e-05	0.000206	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—lung cancer	3.14e-05	0.000206	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—lung cancer	3.14e-05	0.000205	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—lung cancer	3.14e-05	0.000205	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Docetaxel—lung cancer	3.13e-05	0.000205	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—lung cancer	3.13e-05	0.000205	CcSEcCtD
Rabeprazole—Diarrhoea—Paclitaxel—lung cancer	3.09e-05	0.000202	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—lung cancer	3.05e-05	0.0002	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—lung cancer	3.05e-05	0.0002	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—lung cancer	3.05e-05	0.0002	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—lung cancer	3.04e-05	0.000199	CcSEcCtD
Rabeprazole—Abdominal pain—Docetaxel—lung cancer	3.03e-05	0.000198	CcSEcCtD
Rabeprazole—Body temperature increased—Docetaxel—lung cancer	3.03e-05	0.000198	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—lung cancer	3.03e-05	0.000198	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—lung cancer	3.02e-05	0.000198	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—lung cancer	3e-05	0.000197	CcSEcCtD
Rabeprazole—Dizziness—Paclitaxel—lung cancer	2.99e-05	0.000196	CcSEcCtD
Rabeprazole—Nausea—Cisplatin—lung cancer	2.99e-05	0.000196	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—lung cancer	2.97e-05	0.000195	CcSEcCtD
Rabeprazole—Cough—Methotrexate—lung cancer	2.95e-05	0.000193	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—lung cancer	2.93e-05	0.000192	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—lung cancer	2.93e-05	0.000192	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—lung cancer	2.93e-05	0.000192	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—lung cancer	2.93e-05	0.000192	CcSEcCtD
Rabeprazole—Rash—Etoposide—lung cancer	2.9e-05	0.00019	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—lung cancer	2.9e-05	0.00019	CcSEcCtD
Rabeprazole—Headache—Etoposide—lung cancer	2.89e-05	0.000189	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—lung cancer	2.89e-05	0.000189	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—lung cancer	2.88e-05	0.000189	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—lung cancer	2.88e-05	0.000189	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—lung cancer	2.88e-05	0.000189	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—lung cancer	2.87e-05	0.000188	CcSEcCtD
Rabeprazole—Vomiting—Paclitaxel—lung cancer	2.87e-05	0.000188	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—lung cancer	2.87e-05	0.000188	CcSEcCtD
Rabeprazole—Rash—Paclitaxel—lung cancer	2.85e-05	0.000187	CcSEcCtD
Rabeprazole—Dermatitis—Paclitaxel—lung cancer	2.85e-05	0.000186	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—lung cancer	2.84e-05	0.000186	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—lung cancer	2.84e-05	0.000186	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—lung cancer	2.83e-05	0.000186	CcSEcCtD
Rabeprazole—Headache—Paclitaxel—lung cancer	2.83e-05	0.000185	CcSEcCtD
Rabeprazole—Hypersensitivity—Docetaxel—lung cancer	2.82e-05	0.000185	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—lung cancer	2.81e-05	0.000184	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—lung cancer	2.78e-05	0.000182	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—lung cancer	2.76e-05	0.000181	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—lung cancer	2.76e-05	0.000181	CcSEcCtD
Rabeprazole—Asthenia—Docetaxel—lung cancer	2.75e-05	0.00018	CcSEcCtD
Rabeprazole—Nausea—Etoposide—lung cancer	2.74e-05	0.000179	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—lung cancer	2.72e-05	0.000178	CcSEcCtD
Rabeprazole—Pruritus—Docetaxel—lung cancer	2.71e-05	0.000177	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—lung cancer	2.71e-05	0.000177	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—lung cancer	2.7e-05	0.000177	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—lung cancer	2.69e-05	0.000176	CcSEcCtD
Rabeprazole—Nausea—Paclitaxel—lung cancer	2.68e-05	0.000176	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—lung cancer	2.67e-05	0.000175	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—lung cancer	2.64e-05	0.000173	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—lung cancer	2.63e-05	0.000172	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—lung cancer	2.63e-05	0.000172	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—lung cancer	2.63e-05	0.000172	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—lung cancer	2.62e-05	0.000172	CcSEcCtD
Rabeprazole—Diarrhoea—Docetaxel—lung cancer	2.62e-05	0.000172	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—lung cancer	2.59e-05	0.000169	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—lung cancer	2.58e-05	0.000169	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—lung cancer	2.57e-05	0.000169	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—lung cancer	2.55e-05	0.000167	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—lung cancer	2.54e-05	0.000166	CcSEcCtD
Rabeprazole—Dizziness—Docetaxel—lung cancer	2.53e-05	0.000166	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—lung cancer	2.53e-05	0.000166	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—lung cancer	2.51e-05	0.000165	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—lung cancer	2.5e-05	0.000163	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—lung cancer	2.49e-05	0.000163	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—lung cancer	2.49e-05	0.000163	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—lung cancer	2.49e-05	0.000163	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—lung cancer	2.48e-05	0.000163	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—lung cancer	2.48e-05	0.000162	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—lung cancer	2.46e-05	0.000161	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—lung cancer	2.46e-05	0.000161	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—lung cancer	2.45e-05	0.000161	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—lung cancer	2.44e-05	0.00016	CcSEcCtD
Rabeprazole—Vomiting—Docetaxel—lung cancer	2.43e-05	0.000159	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—lung cancer	2.43e-05	0.000159	CcSEcCtD
Rabeprazole—Rash—Docetaxel—lung cancer	2.41e-05	0.000158	CcSEcCtD
Rabeprazole—Dermatitis—Docetaxel—lung cancer	2.41e-05	0.000158	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—lung cancer	2.41e-05	0.000158	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—lung cancer	2.4e-05	0.000157	CcSEcCtD
Rabeprazole—Headache—Docetaxel—lung cancer	2.4e-05	0.000157	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—lung cancer	2.39e-05	0.000157	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—lung cancer	2.39e-05	0.000157	CcSEcCtD
Rabeprazole—Pain—Methotrexate—lung cancer	2.36e-05	0.000155	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—lung cancer	2.35e-05	0.000154	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—lung cancer	2.34e-05	0.000153	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—lung cancer	2.33e-05	0.000153	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—lung cancer	2.31e-05	0.000151	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—lung cancer	2.28e-05	0.000149	CcSEcCtD
Rabeprazole—Nausea—Docetaxel—lung cancer	2.27e-05	0.000149	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—lung cancer	2.27e-05	0.000149	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—lung cancer	2.26e-05	0.000148	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—lung cancer	2.23e-05	0.000146	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—lung cancer	2.19e-05	0.000144	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—lung cancer	2.18e-05	0.000143	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—lung cancer	2.18e-05	0.000143	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.18e-05	0.000143	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—lung cancer	2.16e-05	0.000142	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—lung cancer	2.15e-05	0.000141	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—lung cancer	2.13e-05	0.00014	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—lung cancer	2.12e-05	0.000139	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—lung cancer	2.1e-05	0.000138	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—lung cancer	2.08e-05	0.000136	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—lung cancer	2.04e-05	0.000134	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—lung cancer	2.04e-05	0.000134	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—lung cancer	2.03e-05	0.000133	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—lung cancer	1.98e-05	0.00013	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—lung cancer	1.97e-05	0.000129	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—lung cancer	1.95e-05	0.000128	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—lung cancer	1.95e-05	0.000128	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—lung cancer	1.9e-05	0.000124	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—lung cancer	1.89e-05	0.000124	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—lung cancer	1.89e-05	0.000124	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—lung cancer	1.89e-05	0.000124	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—lung cancer	1.82e-05	0.00012	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—lung cancer	1.76e-05	0.000115	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—lung cancer	1.75e-05	0.000115	CcSEcCtD
Rabeprazole—Rash—Methotrexate—lung cancer	1.74e-05	0.000114	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—lung cancer	1.74e-05	0.000114	CcSEcCtD
Rabeprazole—Headache—Methotrexate—lung cancer	1.73e-05	0.000113	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—lung cancer	1.71e-05	0.000112	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—lung cancer	1.69e-05	0.000111	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—lung cancer	1.64e-05	0.000107	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—lung cancer	1.63e-05	0.000107	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—lung cancer	1.58e-05	0.000103	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—lung cancer	1.52e-05	9.95e-05	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—lung cancer	1.51e-05	9.87e-05	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—lung cancer	1.51e-05	9.86e-05	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—lung cancer	1.5e-05	9.81e-05	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—lung cancer	1.42e-05	9.3e-05	CcSEcCtD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.69e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA2—lung cancer	6.67e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADCY1—lung cancer	6.65e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCG2—lung cancer	6.65e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ENO2—lung cancer	6.53e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HPGDS—lung cancer	6.53e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2E1—lung cancer	6.5e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPP2R1B—lung cancer	6.49e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDOA—lung cancer	6.48e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2A7—lung cancer	6.48e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA1—lung cancer	6.43e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NQO1—lung cancer	6.43e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDOA—lung cancer	6.43e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.4e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCC3—lung cancer	6.36e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SDC4—lung cancer	6.34e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—lung cancer	6.33e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.29e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA3—lung cancer	6.29e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2A6—lung cancer	6.26e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GCLC—lung cancer	6.26e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA3—lung cancer	6.24e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.24e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.23e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKR1C1—lung cancer	6.16e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.13e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADCY1—lung cancer	6.12e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCG2—lung cancer	6.12e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCG2—lung cancer	6.07e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADCY1—lung cancer	6.07e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ENO2—lung cancer	6e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HPGDS—lung cancer	6e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—UGT1A1—lung cancer	5.98e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPP2R1B—lung cancer	5.96e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ENO2—lung cancer	5.95e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HPGDS—lung cancer	5.95e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ENO1—lung cancer	5.93e-06	0.0001	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOA1—lung cancer	5.92e-06	9.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	5.91e-06	9.98e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.91e-06	9.97e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.83e-06	9.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.83e-06	9.85e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—lung cancer	5.82e-06	9.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—STK11—lung cancer	5.79e-06	9.78e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RRM1—lung cancer	5.77e-06	9.74e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA3—lung cancer	5.77e-06	9.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—lung cancer	5.77e-06	9.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GNG11—lung cancer	5.77e-06	9.73e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2A6—lung cancer	5.75e-06	9.71e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GCLC—lung cancer	5.75e-06	9.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.74e-06	9.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GCLC—lung cancer	5.71e-06	9.63e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2A6—lung cancer	5.71e-06	9.63e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.68e-06	9.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDOA—lung cancer	5.49e-06	9.27e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ENO1—lung cancer	5.46e-06	9.21e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.44e-06	9.18e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—B4GALT5—lung cancer	5.43e-06	9.16e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ENO1—lung cancer	5.41e-06	9.13e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—lung cancer	5.4e-06	9.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.39e-06	9.09e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—lung cancer	5.36e-06	9.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA3—lung cancer	5.33e-06	9e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2E1—lung cancer	5.32e-06	8.98e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.32e-06	8.98e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA4—lung cancer	5.28e-06	8.91e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NQO1—lung cancer	5.26e-06	8.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.24e-06	8.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAT—lung cancer	5.22e-06	8.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.19e-06	8.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADCY1—lung cancer	5.19e-06	8.75e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCG2—lung cancer	5.19e-06	8.75e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.15e-06	8.69e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA2—lung cancer	5.15e-06	8.69e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—POMC—lung cancer	5.14e-06	8.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.1e-06	8.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HPGDS—lung cancer	5.09e-06	8.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ENO2—lung cancer	5.09e-06	8.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—lung cancer	5.08e-06	8.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.05e-06	8.53e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CREBBP—lung cancer	5.01e-06	8.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.99e-06	8.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMS—lung cancer	4.98e-06	8.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA1—lung cancer	4.96e-06	8.38e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—lung cancer	4.93e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—lung cancer	4.93e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCC3—lung cancer	4.91e-06	8.29e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2E1—lung cancer	4.89e-06	8.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2A6—lung cancer	4.88e-06	8.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GCLC—lung cancer	4.88e-06	8.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.86e-06	8.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2E1—lung cancer	4.85e-06	8.19e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NQO1—lung cancer	4.84e-06	8.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NQO1—lung cancer	4.8e-06	8.1e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKR1C1—lung cancer	4.75e-06	8.02e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—lung cancer	4.75e-06	8.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—STK11—lung cancer	4.74e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.7e-06	7.93e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—lung cancer	4.69e-06	7.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.65e-06	7.85e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ERCC2—lung cancer	4.63e-06	7.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ENO1—lung cancer	4.62e-06	7.8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UGT1A1—lung cancer	4.62e-06	7.79e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.6e-06	7.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.55e-06	7.67e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.45e-06	7.51e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNG11—lung cancer	4.45e-06	7.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—lung cancer	4.39e-06	7.41e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STK11—lung cancer	4.36e-06	7.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STK11—lung cancer	4.32e-06	7.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAT—lung cancer	4.27e-06	7.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.24e-06	7.16e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDOA—lung cancer	4.24e-06	7.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—lung cancer	4.15e-06	7.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2E1—lung cancer	4.15e-06	7e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—lung cancer	4.14e-06	6.99e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA3—lung cancer	4.11e-06	6.94e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—lung cancer	4.1e-06	6.93e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NQO1—lung cancer	4.1e-06	6.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMS—lung cancer	4.08e-06	6.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.06e-06	6.85e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—lung cancer	4.04e-06	6.81e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—lung cancer	4.03e-06	6.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.01e-06	6.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOA1—lung cancer	4.01e-06	6.76e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADCY1—lung cancer	4e-06	6.75e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG2—lung cancer	4e-06	6.75e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—lung cancer	4e-06	6.75e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.98e-06	6.71e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAT—lung cancer	3.93e-06	6.63e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HPGDS—lung cancer	3.92e-06	6.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ENO2—lung cancer	3.92e-06	6.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.9e-06	6.58e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAT—lung cancer	3.89e-06	6.57e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.87e-06	6.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.84e-06	6.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—lung cancer	3.82e-06	6.45e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—lung cancer	3.82e-06	6.45e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—lung cancer	3.81e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ERCC2—lung cancer	3.79e-06	6.4e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—lung cancer	3.79e-06	6.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCLC—lung cancer	3.76e-06	6.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2A6—lung cancer	3.76e-06	6.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMS—lung cancer	3.75e-06	6.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMS—lung cancer	3.72e-06	6.28e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—lung cancer	3.71e-06	6.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STK11—lung cancer	3.69e-06	6.24e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—lung cancer	3.68e-06	6.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—lung cancer	3.66e-06	6.17e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—lung cancer	3.58e-06	6.04e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ENO1—lung cancer	3.57e-06	6.02e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—lung cancer	3.52e-06	5.93e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ERCC2—lung cancer	3.49e-06	5.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—lung cancer	3.49e-06	5.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—POMC—lung cancer	3.48e-06	5.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.47e-06	5.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ERCC2—lung cancer	3.46e-06	5.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—lung cancer	3.42e-06	5.77e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—EP300—lung cancer	3.41e-06	5.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CREBBP—lung cancer	3.39e-06	5.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAT—lung cancer	3.33e-06	5.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.31e-06	5.58e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOA1—lung cancer	3.28e-06	5.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—lung cancer	3.24e-06	5.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—lung cancer	3.22e-06	5.43e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2E1—lung cancer	3.2e-06	5.4e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMS—lung cancer	3.18e-06	5.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—lung cancer	3.18e-06	5.36e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NQO1—lung cancer	3.16e-06	5.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—lung cancer	3.14e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.14e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOA1—lung cancer	3.02e-06	5.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—lung cancer	2.99e-06	5.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOA1—lung cancer	2.99e-06	5.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—lung cancer	2.98e-06	5.03e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ERCC2—lung cancer	2.95e-06	4.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.86e-06	4.83e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STK11—lung cancer	2.85e-06	4.81e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—POMC—lung cancer	2.85e-06	4.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—lung cancer	2.8e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—lung cancer	2.78e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CREBBP—lung cancer	2.78e-06	4.68e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—lung cancer	2.75e-06	4.65e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—lung cancer	2.73e-06	4.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—lung cancer	2.64e-06	4.45e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—lung cancer	2.63e-06	4.44e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—POMC—lung cancer	2.62e-06	4.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—POMC—lung cancer	2.6e-06	4.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—lung cancer	2.6e-06	4.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAT—lung cancer	2.57e-06	4.33e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOA1—lung cancer	2.56e-06	4.31e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CREBBP—lung cancer	2.55e-06	4.31e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CREBBP—lung cancer	2.53e-06	4.27e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—lung cancer	2.52e-06	4.26e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—lung cancer	2.5e-06	4.22e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMS—lung cancer	2.45e-06	4.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.45e-06	4.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—lung cancer	2.42e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—lung cancer	2.42e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—lung cancer	2.42e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—lung cancer	2.4e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—lung cancer	2.39e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—lung cancer	2.37e-06	4e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—lung cancer	2.33e-06	3.94e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—EP300—lung cancer	2.31e-06	3.9e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—lung cancer	2.3e-06	3.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—lung cancer	2.29e-06	3.87e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ERCC2—lung cancer	2.28e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—lung cancer	2.27e-06	3.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—POMC—lung cancer	2.22e-06	3.75e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CREBBP—lung cancer	2.16e-06	3.65e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—lung cancer	2.11e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—lung cancer	2.09e-06	3.53e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—lung cancer	2.09e-06	3.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—lung cancer	2.07e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—lung cancer	2.06e-06	3.48e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—lung cancer	2.05e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—lung cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—lung cancer	1.98e-06	3.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA1—lung cancer	1.97e-06	3.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—EP300—lung cancer	1.89e-06	3.19e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—lung cancer	1.82e-06	3.08e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—lung cancer	1.81e-06	3.05e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—lung cancer	1.8e-06	3.04e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—lung cancer	1.79e-06	3.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—lung cancer	1.77e-06	2.99e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—EP300—lung cancer	1.74e-06	2.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—EP300—lung cancer	1.72e-06	2.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—POMC—lung cancer	1.71e-06	2.89e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—lung cancer	1.71e-06	2.88e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CREBBP—lung cancer	1.67e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—lung cancer	1.58e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—lung cancer	1.56e-06	2.64e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—lung cancer	1.54e-06	2.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EP300—lung cancer	1.47e-06	2.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—lung cancer	1.4e-06	2.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—lung cancer	1.4e-06	2.36e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—lung cancer	1.38e-06	2.33e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—lung cancer	1.37e-06	2.31e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—lung cancer	1.29e-06	2.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—lung cancer	1.28e-06	2.15e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—lung cancer	1.19e-06	2.01e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—lung cancer	1.14e-06	1.93e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EP300—lung cancer	1.14e-06	1.92e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—lung cancer	1.09e-06	1.84e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—lung cancer	1.05e-06	1.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—lung cancer	1.04e-06	1.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—lung cancer	8.9e-07	1.5e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—lung cancer	8.41e-07	1.42e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—lung cancer	6.87e-07	1.16e-05	CbGpPWpGaD
